Intramuscular injection of human mesenchymal stem cells (hMSCs) engineered to express GDNF and/or VEGF led to a significant improvement in innervated endplates, as indicated by increased AChR cluster formation in an ALS animal model [64]. This evidence concerns the gene GDNF and amyotrophic lateral sclerosis.